# Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer

> **NCT02048150** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 7 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate
- Stage IIB Prostate Cancer
- Stage III Prostate Cancer
- Stage IV Prostate Cancer

## Interventions

- **BIOLOGICAL:** anti-PSMA monoclonal antibody MDX1201-A488
- **PROCEDURE:** robot-assisted laparoscopic surgery
- **OTHER:** diffuse optical imaging
- **OTHER:** pharmacological study
- **OTHER:** Laboratory Biomarker
- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT02048150
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-05
- **Primary completion:** 2018-05-10
- **Final completion:** 2023-02-01
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02048150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02048150, "Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02048150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*